Literature DB >> 26282596

Chronic intermittent toluene inhalation in adolescent rats results in metabolic dysfunction with altered glucose homeostasis.

A L W Dick1,2, A Simpson1, A Qama1, Z Andrews3, A J Lawrence1, J R Duncan1,4.   

Abstract

BACKGROUND AND
PURPOSE: Abuse of toluene-containing inhalants is an increasing public health problem, especially among adolescents. Abuse during adolescence is associated with emaciation, while industrial exposure leads to altered glycaemic control suggesting metabolic instability. However, the relationship between adolescent inhalant abuse and metabolic dysfunction remains unknown. EXPERIMENTAL APPROACH: To model human abuse patterns, we exposed male adolescent Wistar rats [postnatal day (PND) 27] to chronic intermittent inhaled toluene (CIT, 10,000 ppm) or air (control) for 1 h·day(-1) , three times a week for 4 weeks. Feeding and body composition were monitored. After 4 weeks, circulating metabolic hormone concentrations and responses to a glucose tolerance test (GTT) were measured. Dietary preference was measured by giving animals access to either a 'western diet' plus standard chow (WC + SC) or standard chow alone during 4 weeks of abstinence. Metabolic hormones and GTT were subsequently measured. KEY
RESULTS: Adolescent CIT exposure significantly retarded weight gain, altered body composition, circulating metabolic hormones and responses to a GTT. While reduced body weight persisted, responses to a GTT and circulating hormones appeared to normalize for animals on standard chow following abstinence. In CIT-exposed WC + SC rats, we observed impaired glucose tolerance associated with altered metabolic hormones. Analysis of hypothalamic genes revealed differential expression profiles in CIT-exposed rats following both the exposure period and abstinence, suggesting a central contribution to inhalant-induced metabolic dysfunction. CONCLUSION AND IMPLICATIONS: CIT exposure during adolescence has long-term effects on metabolic function, which may increase the risk of disorders related to energy balance and glycaemic control.
© 2015 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26282596      PMCID: PMC4687795          DOI: 10.1111/bph.13284

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  54 in total

Review 1.  Trajectories of brain development: point of vulnerability or window of opportunity?

Authors:  Susan L Andersen
Journal:  Neurosci Biobehav Rev       Date:  2003 Jan-Mar       Impact factor: 8.989

2.  Guidelines for reporting experiments involving animals: the ARRIVE guidelines.

Authors:  J C McGrath; G B Drummond; E M McLachlan; C Kilkenny; C L Wainwright
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 3.  Inhalant misuse in youth: time for a coordinated response.

Authors:  Dan I Lubman; Leanne Hides; Murat Yücel
Journal:  Med J Aust       Date:  2006-09-18       Impact factor: 7.738

Review 4.  Inhalant abuse among adolescents: neurobiological considerations.

Authors:  D I Lubman; M Yücel; A J Lawrence
Journal:  Br J Pharmacol       Date:  2008-03-10       Impact factor: 8.739

5.  Inhalants to heroin: a prospective analysis from adolescence to adulthood.

Authors:  E O Johnson; C G Schütz; J C Anthony; M E Ensminger
Journal:  Drug Alcohol Depend       Date:  1995-12       Impact factor: 4.492

6.  Plasma IL-6 concentration is inversely related to insulin sensitivity, and acute-phase proteins associate with glucose and lipid metabolism in healthy subjects.

Authors:  M K Heliövaara; A-M Teppo; S L Karonen; J A Tuominen; P Ebeling
Journal:  Diabetes Obes Metab       Date:  2005-11       Impact factor: 6.577

7.  Leptin impairs metabolic actions of insulin in isolated rat adipocytes.

Authors:  G Müller; J Ertl; M Gerl; G Preibisch
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

8.  Chronic intermittent toluene inhalation in adolescent rats results in metabolic dysfunction with altered glucose homeostasis.

Authors:  A L W Dick; A Simpson; A Qama; Z Andrews; A J Lawrence; J R Duncan
Journal:  Br J Pharmacol       Date:  2015-10-22       Impact factor: 8.739

9.  Effects of fasting on blood plasma levels, metabolism and metabolic effects of epinephrine and norepinephrine in steers.

Authors:  D Fröhli; J W Blum
Journal:  Acta Endocrinol (Copenh)       Date:  1988-06

10.  Chronic intermittent toluene inhalation in adolescent rats alters behavioural responses to amphetamine and MK801.

Authors:  Jhodie Rubina Duncan; Sarah Jane Gibbs; Andrew John Lawrence
Journal:  Eur Neuropsychopharmacol       Date:  2013-06-26       Impact factor: 4.600

View more
  5 in total

1.  The association between oil spill cleanup-related total hydrocarbon exposure and diabetes.

Authors:  H V Jardel; L S Engel; K G Lawrence; P A Stewart; M R Stenzel; M D Curry; R K Kwok; D P Sandler
Journal:  Environ Res       Date:  2022-06-01       Impact factor: 8.431

2.  Molecular evidence of the amelioration of toluene induced encephalopathy by human breast milk mesenchymal stem cells.

Authors:  Omaima I Abdel Hamid; Ayat M Domouky; Yara M El-Fakharany
Journal:  Sci Rep       Date:  2022-06-02       Impact factor: 4.996

3.  Chronic intermittent toluene inhalation in adolescent rats results in metabolic dysfunction with altered glucose homeostasis.

Authors:  A L W Dick; A Simpson; A Qama; Z Andrews; A J Lawrence; J R Duncan
Journal:  Br J Pharmacol       Date:  2015-10-22       Impact factor: 8.739

4.  Integrated Metagenomic and Transcriptomic Analyses Reveal the Dietary Dependent Recovery of Host Metabolism From Antibiotic Exposure.

Authors:  Bingbing Li; Huihui Qiu; Ningning Zheng; Gaosong Wu; Yu Gu; Jing Zhong; Ying Hong; Junli Ma; Wen Zhou; Lili Sheng; Houkai Li
Journal:  Front Cell Dev Biol       Date:  2021-06-18

Review 5.  The effect of adolescent inhalant abuse on energy balance and growth.

Authors:  Rose Crossin; Ashleigh Qama; Zane B Andrews; Andrew J Lawrence; Jhodie R Duncan
Journal:  Pharmacol Res Perspect       Date:  2019-07-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.